Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines
Product Brochure
Sorafenib 200mg Tablets.
₹ 1,800/Bottle
Packaging Size
120 Tablets
Strength
200 mg
Form
Tablet
Usage/Application
Hospital
Prescription/Non prescription
Prescription
Country of Origin
Made in India
Availability
In Stock
Sorafenib is a medication used to treat certain types of cancer, including liver cancer (hepatocellular carcinoma), kidney cancer (advanced renal cell carcinoma), and thyroid cancer (differentiated thyroid carcinoma).
Sorafenib is a type of medication known as a kinase inhibitor. It works by interfering with the growth and spread of cancer cells in the body. Specifically, sorafenib blocks the action of certain proteins (kinases) that are involved in the growth and spread of cancer cells, as well as in the formation of blood vessels that tumors need to grow.
Exports To: United States Of America | Canada | Saudi Arabia | Germany | United Kingdom
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
02-02-2023
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Mar 2023
GST
27AAICN5916B1ZK
Import Export Code (IEC)
AAICN*****
Exports to
United States Of America | Canada | Saudi Arabia | Germany | United Kingdom
Established in the year of 2016, We “Narix Pharmaceuticals Private Limited” are Wholesaler Exporter, Distributor, Importer and Supplier of an Pharmaceutical Tablets, Oral Jelly, Pharmaceutical Capsules, Pharmaceutical Soap, Pharmaceutical Cream, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers. For our accomplishment story, we are grateful to our Mr. Naman, whose continual backing and direction have been useful to us for attaining exponential development in the current market.
